The innate defense regulator peptides IDR-HH2, IDR-1002, and IDR-1018 modulate human neutrophil functions

Journal of Leukocyte Biology

Volumn 94, Issue 1, 2013, Pages 159-170

  Niyonsaba, François ^a   Madera, Laurence ^b   Afacan, Nicole ^b   Okumura, Ko ^a   Ogawa, Hideoki ^a   Hancock, Robert E W ^b  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cell activation; Chemotaxis; Host defense peptide; Immunomodulation

Indexed keywords

ALPHA DEFENSIN; BACTENECIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD11B ANTIGEN; CD18 ANTIGEN; CD64 ANTIGEN; CD66B ANTIGEN; CHEMOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HOST DEFENSE PEPTIDE; INTERLEUKIN 10; INTERLEUKIN 8; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MYELOPEROXIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN IDR 1002; PROTEIN IDR 1018; PROTEIN IDR HH2; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL TYPE; CONTROLLED STUDY; DEGRANULATION; ENDOTHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL ACTIVATION; CHEMOTAXIS; HOST DEFENSE PEPTIDE; IMMUNOMODULATION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; CATTLE; CELL ADHESION; CELLS, CULTURED; CHEMOTAXIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; NEUTROPHIL ACTIVATION; NEUTROPHILS; REACTIVE OXYGEN SPECIES;

BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI;

EID: 84879570321     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1012497     Document Type: Article

References (61)

1. Hancock, R. E., Chapple, D. S. (1999) Peptide antibiotics. Antimicrob. Agents Chemother. 43, 1317-1323.
2. Niyonsaba, F., Nagaoka, I., Ogawa, H. (2006) Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties. Crit. Rev. Immunol. 26, 545-576.
3. Niyonsaba, F., Nagaoka, I., Ogawa, H., Okumura, K. (2009) Multifunctional antimicrobial proteins and peptides: natural activators of immune systems. Curr. Pharm. Des. 15, 2393-2413.
4. Oppenheim, J. J., Yang, D. (2005) Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365.
5. Kruse, T., Kristensen, H. H. (2008) Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents. Expert Rev. Anti Infect. Ther. 6, 887-895.
6. Diamond, G., Beckloff, N., Weinberg, A., Kisich, K. O. (2009) The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15, 2377-2392.
7. Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A., Lee, K., Doria, S., Hamill, P., Yu, J. J., Li, Y., Donini, O., Guarna, M. M., Finlay, B. B., North, J. R., Hancock, R. E. W. (2007) An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25, 465-472.
8. Nijnik, A., Madera, L., Ma, S., Waldbrook, M., Elliott, M. R., Easton, D. M., Mayer, M. L., Mullaly, S. C., Kindrachuk, J., Jenssen, H., Hancock, R. E. W. (2010) Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J. Immunol. 184, 2539-2550.
9. Yeung, A. T., Gellatly, S. L., Hancock, R. E. W. (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell. Mol. Life Sci. 68, 2161-2176.
10. Hancock, R. E. W., Nijnik, A., Philpott, D. J. (2012) Modulating immunity as a therapy for bacterial infections. Nat. Rev. Microbiol. 10, 243-254.
11. Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., Nagaoka, I. (2001) Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31, 1066-1075.
12. Chen, X., Niyonsaba, F., Ushio, H., Hara, M., Yokoi, H., Matsumoto, K., Saito, H., Nagaoka, I., Ikeda, S., Okumura, K., Ogawa, H. (2007) Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur. J. Immunol. 37, 434-444.
13. Lau, Y. E., Bowdish, D. M., Cosseau, C., Hancock, R. E. W., Davidson, D. J. (2006) Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am. J. Respir. Cell Mol. Biol. 34, 399-409.
14. Easton, D. M., Nijnik, A., Mayer, M. L., Hancock, R. E. W. (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 27, 582-590.
15. Kindrachuk, J., Jenssen, H., Elliott, M., Townsend, R., Nijnik, A., Lee, S. F., Gerdts, V., Babiuk, L. A., Halperin, S. A., Hancock, R. E. W. (2009) A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Vaccine 27, 4662-4671.
16. Gracia, A., Polewicz, M., Halperin, S. A., Hancock, R. E. W., Potter, A. A., Babiuk, L. A., Gerdts, V. (2011) Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Vaccine 29, 1595-1604.
17. Brown, T. H., David, J., Acosta-Ramirez, E., Moore, J. M., Lee, S., Zhong, G., Hancock, R. E. W., Xing, Z., Halperin, S. A., Wang, J. (2012) Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/ HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection. Vaccine 30, 350-360.
18. Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R., Elliott, M., Hilpert, K., Cheng, J. T., Hancock, R. E. W., Straus, S. K. (2010) Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 17, 970-980.
19. Achtman, A. H., Pilat, S., Law, C. W., Lynn, D. J., Janot, L., Mayer, M. L., Ma, S., Kindrachuk, J., Finlay, B. B., Brinkman, F. S., Smyth, G. K., Hancock, R. E. W., Schofield, L. (2012) Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Sci. Transl. Med. 4, 135ra64.
20. Lee, H. Y., Bae, Y. S. (2008) The anti-infective peptide, innate defenseregulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor. Biochem. Biophys. Res. Commun. 369, 573-578.
21. Madera, L., Hancock, R. E. W. (2012) Synthetic immunomodulatory peptide IDR-1002 enhances monocyte migration and adhesion on fibronectin. J. Innate Immun. 4, 553-568.
22. Theilgaard-Monch, K., Porse, B. T., Borregaard, N. (2006) Systems biology of neutrophil differentiation and immune response. Curr. Opin. Immunol. 18, 54-60.
23. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
24. Niyonsaba, F., Ogawa, H., Nagaoka, I. (2004) Human β-defensin-2 functions as a chemotactic agent for tumour necrosis factor-α-treated human neutrophils. Immunology 111, 273-281.
25. Zheng, Y., Niyonsaba, F., Ushio, H., Nagaoka, I., Ikeda, S., Okumura, K., Ogawa, H. (2007) Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human α-defensins from neutrophils. Br. J. Dermatol. 157, 1124-1131.
26. Zheng, Y., Niyonsaba, F., Ushio, H., Ikeda, S., Nagaoka, I., Okumura, K., Ogawa, H. (2008) Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 124, 357-367.
27. Mookherjee, N., Brown, K. L., Bowdish, D. M., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., Powers, J. P., Bryan, J., Brinkman, F. S., Hancock, R. E. W. (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176, 2455-2464.
28. Edgell, C. J., McDonald, C. C., Graham, J. B. (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80, 3734-3737.
29. Simon, S. I., Green, C. E. (2005) Molecular mechanics and dynamics of leukocyte recruitment during inflammation. Annu. Rev. Biomed. Eng. 7, 151-185.
30. Malcolm, K. C., Arndt, P. G., Manos, E. J., Jones, D. A., Worthen, G. S. (2003) Microarray analysis of lipopolysaccharide-treated human neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L663-L670.
31. Yomogida, S., Nagaoka, I., Yamashita, T. (1997) Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 116, 99-107.
32. Ganz, T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720.
33. Zanetti, M., Gennaro, R., Romeo, D. (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374, 1-5.
34. Ley, K., Gaehtgens, P., Fennie, C., Singer, M. S., Lasky, L. A., Rosen, S. D. (1991) Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 77, 2553-2555.
35. Berton, G., Lowell, C. A. (1999) Integrin signalling in neutrophils and macrophages. Cell. Signal. 11, 621-635.
36. Arnaout, M. A. (1990) Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75, 1037-1050.
37. Nakayama, H., Yoshizaki, F., Prinetti, A., Sonnino, S., Mauri, L., Takamori, K., Ogawa, H., Iwabuchi, K. (2008) Lyn-coupled LacCerenriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J. Leukoc. Biol. 83, 728-741.
38. Schymeinsky, J., Mocsai, A., Walzog, B. (2007) Neutrophil activation via β2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb. Haemost. 98, 262-273.
39. Skubitz, K. M., Campbell, K. D., Skubitz, A. P. (1996) CD66a, CD66b, CD66c, and CD66d each independently stimulate neutrophils. J. Leukoc. Biol. 60, 106-117.
40. Ureten, K., Ertenli, I., Ozturk, M. A., Kiraz, S., Onat, A. M., Tuncer, M., Okur, H., Akdogan, A., Apras, S., Calguneri, M. (2005) Neutrophil CD64 expression in Behcet's disease. J. Rheumatol. 32, 849-852.
41. Segal, A. W. (2005) How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197-223.
42. Faurschou, M., Borregaard, N. (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317-1327.
43. Rice, W. G., Ganz, T., Kinkade, J. M. Jr., Selsted, M. E., Lehrer, R. I., Parmley, R. T. (1987) Defensin-rich dense granules of human neutrophils. Blood 70, 757-765.
44. Sengeløv, H., Kjeldsen, L., Borregaard, N. (1993) Control of exocytosis in early neutrophil activation. J. Immunol. 150, 1535-1543.
45. Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., Lehrer, R. I. (1985) Primary structures of three human neutrophil defensins. J. Clin. Invest. 76, 1436-1439.
46. Wilde, C. G., Griffith, J. E., Marra, M. N., Snable, J. L., Scott, R. W. (1989) Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J. Biol. Chem. 264, 11200-11203.
47. Nagaoka, I., Hirota, S., Yomogida, S., Ohwada, A., Hirata, M. (2000) Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49, 73-79.
48. Panyutich, A. V., Panyutich, E. A., Krapivin, V. A., Baturevich, E. A., Ganz, T. (1993) Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J. Lab. Clin. Med. 122, 202-207.
49. Parameswaran, G. I., Sethi, S., Murphy, T. F. (2011) Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD. Chest 140, 611-617.
50. Eyles, J. L., Roberts, A. W., Metcalf, D., Wicks, I. P. (2006) Granulocyte colony-stimulating factor and neutrophils-forgotten mediators of inflammatory disease. Nat. Clin. Pract. Rheumatol. 2, 500-510.
51. Nathan, C. (2006) Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6, 173-182.
52. Fang, F. C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2, 820-832.
53. Kobayashi, S. D., Braughton, K. R., Whitney, A. R., Voyich, J. M., Schwan, T. G., Musser, J. M., DeLeo, F. R. (2003) Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc. Natl. Acad. Sci. USA 100, 10948-10953.
54. Kobayashi, S. D., Voyich, J. M., Somerville, G. A., Braughton, K. R., Malech, H. L., Musser, J. M., DeLeo, F. R. (2003) An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J. Leukoc. Biol. 73, 315-322.
55. Nagaoka, I., Tamura, H., Hirata, M. (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176, 3044-3052.
56. Nagaoka, I., Suzuki, K., Murakami, T., Niyonsaba, F., Tamura, H., Hirata, M. (2010) Evaluation of the effect of α-defensin human neutrophil peptides on neutrophil apoptosis. Int. J. Mol. Med. 26, 925-934.
57. Nagaoka, I., Niyonsaba, F., Tsutsumi-Ishii, Y., Tamura, H., Hirata, M. (2008) Evaluation of the effect of human β-defensins on neutrophil apoptosis. Int. Immunol. 20, 543-553.
58. Yu, H. B., Kielczewska, A., Rozek, A., Takenaka, S., Li, Y., Thorson, L., Hancock, R. E. W., Guarna, M. M., North, J. R., Foster, L. J., Donini, O., Finlay, B. B. (2009) Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide. J. Biol. Chem. 284, 36007-36011.
59. Mookherjee, N., Lippert, D. N., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., Pistolic, J., Gardy, J., Miri, P., Naseer, M., Foster, L. J., Hancock, R. E. W. (2009) Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 183, 2688-2696.
60. Kuroki, M., O'Flaherty, J. T. (1997) Differential effects of a mitogenactivated protein kinase kinase inhibitor on human neutrophil responses to chemotactic factors. Biochem. Biophys. Res. Commun. 232, 474-477.
61. Ballif, B. A., Blenis, J. (2001) Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12, 397-408.